News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|August 23, 2024

Navigating Treatment Challenges in Chronic Skin Conditions

A dermatologist outlines the limitations and obstacles encountered with current therapeutic options for treating dermatologic conditions.

Episodes in this series

This series features 1 KOL.

EP. 1 Navigating the Challenges of Respiratory Diseases

1 KOL is featured in this series.

EP. 2 The Impact of Atopic Dermatitis and Prurigo Nodularis

This series features 1 KOL.

EP. 3 Linking Type 2 Inflammation to Asthma and COPD

This series features 1 KOL.

EP. 4 Impact of Exacerbations in Type 2 Inflammatory Respiratory Diseases

1 KOL is featured in this series.

EP. 5 Type 2 Inflammation: The Link Between AD and PN

1 KOL is featured in this series.

EP. 6 Personalizing Treatment Selection

1 KOL is featured in this series.

EP. 7 Navigating Treatment Challenges in Chronic Skin Conditions

1 KOL is featured in this series.

EP. 8 Role of Biologics in Dermatological Care

This series features 1 KOL.

EP. 9 Biomarkers as Tools in Management of Type 2 Inflammation

This series features 1 KOL.

EP. 10 Strategies to Manage Type 2 Inflammation in Respiratory Diseases

1 KOL is featured in this series.

EP. 11 Addressing Unmet Needs and Emerging Agents

This series features 1 KOL.

EP. 12 Future Directions for Type 2 Inflammation Management

1 KOL is featured in this series.

EP. 13 Type 2 Inflammatory Diseases and Impact on Quality of Life

1 KOL is featured in this series.

EP. 14 Type 2 Inflammation Biomarkers

1 KOL is featured in this series.

EP. 15 How Type 2 Inflammation Influences Treatment Choices

1 KOL is featured in this series.

EP. 16 Complications of Uncontrolled Disease and Management of Comorbidities

1 KOL is featured in this series.

EP. 17 Patient Education and Emerging Therapies

1 KOL is featured in this series.

EP. 18 Unmet Needs and Future Research

Video content above is prompted by the following:

What challenges have patients faced with the available treatment options?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Andrew T. Kuykendall, MD, associate member in the Department of Hematology at Moffitt Cancer Center and lead investigator for VERIFY | Image: Moffitt

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

August 29th 2026

Pleural fluid cytology showing involvement by malignant cells of a mantle cell lymphoma, pleomorphic variant. | Image: David Litman for AdobeStock

Study Measures Both Patient and Physician Preferences After Covalent BTK Inhibitors in R/R MCL

August 29th 2026

The Cost of Waiting: An Endocrinologist's Economic Case for Earlier Metabolic Disease Intervention

ByJaime Almandoz, MD, MBA

August 28th 2026

SYNCHRONIZE-1 Through an Endocrinologist's Lens: Weight Loss Quality, Visceral Fat, and Liver Fat Reduction

ByJaime Almandoz, MD, MBA

August 28th 2026

Child receiving a shot | Image credit: Mediteraneo - stock.adobe.com

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk

BySabrina McCrear

August 27th 2026

Trending on AJMC

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

Never-Screened Cervical Cancer Rates Climb Among US Women